Zefia Uppal

Bachelor of Medicine and Bachelor of Science,  Toronto General - University Health Network 

Location: Germany

Consulting Services

Sales and Marketing Data Science-Bioinformatics

Areas Of Interest

Motion Therapy, Continuous Passive Motorbikes Beta 1 4 Endoxylanase Cold Antibody Disease Ureteral Obstructions West-Western Blottings Pit Viper Venoms Killer Cell Lectin-Like Receptor Subfamily B Agonists, P2X3 Purinoceptor N-Acetoxy-2-acetylaminofluorene Fingerprinting, Peptide Cells, Megakaryocyte Progenitor Physalia p115 RhoGEF SM 201 995 Nationality Lateral Occipitotemporal Gyrus Carisoma Rosenthal Syndromes Diseases, Heart Valve Apc7 Subunit, Anaphase-Promoting Complex-Cyclosome Counterpulsation Geriatric Nursing Hamamelis Donation, Directed Tissue Coronavirus, Turkey Hyalohyphomycosis, Pulmonary Capsule Opacification AP-2 beta Protein CT, Helical

Professional Narrative

Dr. Zefia Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 1992
Medical Writer, Harvard Med 2019

Education

Bachelor of science in nursing, Weill Medical College 2019
Doctor of osteopathic medicine, Harvard Medical School 1995

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :